BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Center For Technology Licensing - ECPv6.11.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://ctl.cornell.edu
X-WR-CALDESC:Events for Center For Technology Licensing
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20220524T130000
DTEND;TZID=UTC:20220524T140000
DTSTAMP:20260404T154054
CREATED:20220512T220404Z
LAST-MODIFIED:20220512T220404Z
UID:10000272-1653397200-1653400800@ctl.cornell.edu
SUMMARY:CTL@WCM Special Panel on Drug Repurposing
DESCRIPTION:Can you teach an old drug new tricks? Recent successes in repositioning existing drugs – from esketamine for treatment-resistant depression to remdesivir – originally developed to treat hepatitis C\, tested for Ebola before being approved as a treatment for COVID 19 – point to potential upsides. The challenges\, however\, are many: from challenging IP prospects to skeptical investors. We have assembled an expert panel to discuss with us the enticing shortcuts repurposing may offer\, the pitfalls it brings\, and how to develop strategies to overcome them. \nJoin us at the second virtual CTL@WCM Special Panel\, where innovators\, IP experts\, and regulators gather to assess the landscape and talk about the opportunities. \nFeatured panelists: \n\nDr. Bruce Bloom\, Chief Collaboration Officer\, Healx\nEyal Barash\, J.D.\, M.S\, Founder of Barash Law\nValentyna Chebanova\, Sr. Manager of Business Development at Tarsus Pharmaceuticals\n\nModerated by Lisa Placanica\, Senior Managing Director\, Center for Technology Licensing at Weill Cornell Medicine \n  \nRegister here.
URL:https://ctl.cornell.edu/event/ctlwcm-special-panel-on-drug-repurposing
CATEGORIES:CTL Events
ATTACH;FMTTYPE=:
END:VEVENT
END:VCALENDAR